STING1 and cervical cancer: Recent studies have shown that activation of STING/TBK1 inhibits tumor growth by degrading the HPV16/18 E7 oncoprotein in cervical cancer.[14] Here, we wished to explore whether the BAG2‐STING axis exerts tumor suppressive effects by affecting the degradation of HPV E7 oncoproteins.